Published in Arthritis Res Ther on January 11, 2005
Autoantigens in systemic autoimmunity: critical partner in pathogenesis. J Intern Med (2009) 1.07
The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases. Immunol Rev (2010) 0.92
The RNA interference pathway: a new target for autoimmunity. Arthritis Res Ther (2006) 0.79
Caspase-mediated cleavage of the exosome subunit PM/Scl-75 during apoptosis. Arthritis Res Ther (2007) 0.79
Human parvovirus B19 nonstructural protein NS1 enhanced the expression of cleavage of 70 kDa U1-snRNP autoantigen. J Biomed Sci (2010) 0.78
Current practice in laboratory diagnostics of autoimmune diseases in Croatia. Survey of the Working group for laboratory diagnostics of autoimmune diseases of the Croatian Society of Medical Biochemistry and Laboratory Medicine. Biochem Med (Zagreb) (2016) 0.75
U1-RNP and Toll-like receptors in the pathogenesis of mixed connective tissue diseasePart II. Endosomal TLRs and their biological significance in the pathogenesis of mixed connective tissue disease. Reumatologia (2015) 0.75
U1-RNP and TLR receptors in the pathogenesis of mixed connective tissue diseasePart I. The U1-RNP complex and its biological significance in the pathogenesis of mixed connective tissue disease. Reumatologia (2015) 0.75
Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A (1979) 14.61
Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med (1972) 11.51
Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum (2003) 10.65
Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum (2004) 7.79
Structure of spliceosomal snRNPs and their role in pre-mRNA splicing. Biochim Biophys Acta (1990) 5.06
Split genes and RNA splicing. Cell (1994) 4.94
Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum (1990) 3.37
Anti-RNP monoclonal antibodies derived from a mouse strain with lupus-like autoimmunity. J Immunol (1982) 3.29
Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med (1996) 3.16
Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med (1999) 2.81
Mixed connective tissue disease: to be or not to be? Arthritis Rheum (1998) 2.58
Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem (1994) 2.51
Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ (1999) 2.02
Death, autoantigen modifications, and tolerance. Arthritis Res (2000) 1.75
Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum (1998) 1.39
Secondary necrosis is a source of proteolytically modified forms of specific intracellular autoantigens: implications for systemic autoimmunity. Arthritis Rheum (2001) 1.18
The appearance of U1 RNP antibody specificities in sequential autoimmune human antisera follows a characteristic order that implicates the U1-70 kd and B'/B proteins as predominant U1 RNP immunogens. Arthritis Rheum (2001) 1.11
Changes in anti-U1 RNA antibody levels correlate with disease activity in patients with systemic lupus erythematosus overlap syndrome. Arthritis Rheum (1992) 1.04
Apoptotic U1-70 kd is antigenically distinct from the intact form of the U1-70-kd molecule. Arthritis Rheum (2002) 1.03
A major, novel systemic lupus erythematosus autoantibody class recognizes the E, F, and G Sm snRNP proteins as an E-F-G complex but not in their denatured states. Arthritis Rheum (1997) 1.00
The U1 snRNP complex: an autoantigen in connective tissue diseases. An update. Clin Exp Rheumatol (1997) 0.99
T cell immunity in connective tissue disease patients targets the RNA binding domain of the U1-70kDa small nuclear ribonucleoprotein. J Immunol (2002) 0.98
Ribonucleoprotein complexes as autoantigens. Curr Opin Immunol (1995) 0.96
Autoantibody recognition of distinctly modified forms of the U1-70-kd antigen is associated with different clinical disease manifestations. Arthritis Rheum (2000) 0.95
The fate of U1 snRNP during anti-Fas induced apoptosis: specific cleavage of the U1 snRNA molecule. Cell Death Differ (2000) 0.93
A major B cell epitope present on the apoptotic but not the intact form of the U1-70-kDa ribonucleoprotein autoantigen. J Immunol (2004) 0.90
Longitudinal study of interleukin-10, tumor necrosis factor-alpha, anti-U1-snRNP antibody levels and disease activity in patients with mixed connective tissue disease. Scand J Rheumatol (2001) 0.85
Characterization of recombinant human autoantibody fragments directed toward the autoantigenic U1-70K protein. Eur J Immunol (2000) 0.83
Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus. Rev Rhum Engl Ed (1998) 0.81
The fate of the U1 snRNP autoantigen during apoptosis: implications for systemic autoimmunity. Isr Med Assoc J (2002) 0.81
Expression of autoantibodies to recombinant (U1) RNP-associated 70K antigen in systemic lupus erythematosus. Clin Immunol Immunopathol (1990) 0.81
Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum (2003) 10.65
PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays (2003) 5.04
Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med (2002) 4.54
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther (2004) 2.58
Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum (2005) 2.30
Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum (2004) 2.25
Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res (2001) 2.18
The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum (2004) 2.12
Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis. Arthritis Res Ther (2004) 2.05
Anti-CCP antibodies: the past, the present and the future. Nat Rev Rheumatol (2011) 2.00
Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum (2003) 1.88
Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines. Ann Rheum Dis (2006) 1.62
Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility. Nat Genet (2012) 1.61
Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Ann Rheum Dis (2010) 1.59
Dis3-like 1: a novel exoribonuclease associated with the human exosome. EMBO J (2010) 1.57
Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis. Ann N Y Acad Sci (2008) 1.51
Citrulline is an Essential Constituent of Antigenic Determinants Recognized by Rheumatoid Arthritis-specific Autoantibodies. 1998. J Immunol (2015) 1.47
Mutual interactions between subunits of the human RNase MRP ribonucleoprotein complex. Nucleic Acids Res (2004) 1.45
The exosome, a molecular machine for controlled RNA degradation in both nucleus and cytoplasm. Eur J Cell Biol (2004) 1.44
The human Imp3 and Imp4 proteins form a ternary complex with hMpp10, which only interacts with the U3 snoRNA in 60-80S ribonucleoprotein complexes. Nucleic Acids Res (2003) 1.41
C1D and hMtr4p associate with the human exosome subunit PM/Scl-100 and are involved in pre-rRNA processing. Nucleic Acids Res (2007) 1.38
The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia. Ann Rheum Dis (2010) 1.31
Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker. Clin Chim Acta (2004) 1.27
Preventing thiol-yne addition improves the specificity of strain-promoted azide-alkyne cycloaddition. Bioconjug Chem (2012) 1.27
The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis. Arthritis Res Ther (2010) 1.26
MPP6 is an exosome-associated RNA-binding protein involved in 5.8S rRNA maturation. Nucleic Acids Res (2005) 1.24
Both endonucleolytic and exonucleolytic cleavage mediate ITS1 removal during human ribosomal RNA processing. J Cell Biol (2013) 1.23
The hU3-55K protein requires 15.5K binding to the box B/C motif as well as flanking RNA elements for its association with the U3 small nucleolar RNA in Vitro. J Biol Chem (2002) 1.23
Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis. J Rheumatol (2003) 1.23
Protein-protein interactions between human exosome components support the assembly of RNase PH-type subunits into a six-membered PNPase-like ring. J Mol Biol (2002) 1.22
Human cell growth requires a functional cytoplasmic exosome, which is involved in various mRNA decay pathways. RNA (2007) 1.22
Role of pre-rRNA base pairing and 80S complex formation in subnucleolar localization of the U3 snoRNP. Mol Cell Biol (2004) 1.21
Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro. J Mol Biol (2007) 1.21
The rheumatoid arthritis synovial fluid citrullinome reveals novel citrullinated epitopes in apolipoprotein E, myeloid nuclear differentiation antigen, and β-actin. Arthritis Rheum (2013) 1.17
Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis. Autoimmun Rev (2006) 1.16
Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis. Ann Neurol (2013) 1.16
Nucleolin associates with a subset of the human Ro ribonucleoprotein complexes. J Mol Biol (2002) 1.16
Periodontal pathogens directly promote autoimmune experimental arthritis by inducing a TLR2- and IL-1-driven Th17 response. J Immunol (2014) 1.15
Addition of poly(A) and poly(A)-rich tails during RNA degradation in the cytoplasm of human cells. Proc Natl Acad Sci U S A (2010) 1.15
Rabip4' is an effector of rab5 and rab4 and regulates transport through early endosomes. Mol Biol Cell (2003) 1.15
The association of the human PM/Scl-75 autoantigen with the exosome is dependent on a newly identified N terminus. J Biol Chem (2003) 1.07
The human La (SS-B) autoantigen interacts with DDX15/hPrp43, a putative DEAH-box RNA helicase. RNA (2002) 1.07
Protein-protein interactions of hCsl4p with other human exosome subunits. J Mol Biol (2002) 1.05
PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome. Arthritis Rheum (2004) 1.02
Angle-scanning SPR imaging for detection of biomolecular interactions on microarrays. Biosens Bioelectron (2007) 1.02
Autoantibodies directed to novel components of the PM/Scl complex, the human exosome. Arthritis Res (2001) 1.02
Citrullination of central nervous system proteins during the development of experimental autoimmune encephalomyelitis. J Comp Neurol (2005) 1.01
Biomolecular interaction monitoring of autoantibodies by scanning surface plasmon resonance microarray imaging. J Am Chem Soc (2007) 1.01
Cutting edge diagnostics in rheumatology: the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology. Arthritis Rheum (2004) 1.01
Differential association of protein subunits with the human RNase MRP and RNase P complexes. RNA (2006) 1.00
Heterodimerization regulates RNase MRP/RNase P association, localization, and expression of Rpp20 and Rpp25. RNA (2006) 1.00
Absence of citrulline-specific autoantibodies in animal models of autoimmunity. Arthritis Rheum (2004) 1.00
All you wanted to know about anti-CCP but were afraid to ask. Autoimmun Rev (2010) 1.00
Are the Ro RNP-associated Y RNAs concealing microRNAs? Y RNA-derived miRNAs may be involved in autoimmunity. Bioessays (2011) 0.99
Mapping of citrullinated fibrinogen B-cell epitopes in rheumatoid arthritis by imaging surface plasmon resonance. Arthritis Res Ther (2010) 0.99
The human exosome and disease. Adv Exp Med Biol (2010) 0.98
ABAP: antibody-based assay for peptidylarginine deiminase activity. Anal Biochem (2007) 0.96
Viperin, a key player in the antiviral response. Microbes Infect (2011) 0.96
Elevated levels of fibrinogen-derived endogenous citrullinated peptides in synovial fluid of rheumatoid arthritis patients. Arthritis Res Ther (2012) 0.95
Cell and molecular biology of the exosome: how to make or break an RNA. Int Rev Cytol (2006) 0.95
Heterodimerization of the human RNase P/MRP subunits Rpp20 and Rpp25 is a prerequisite for interaction with the P3 arm of RNase MRP RNA. Nucleic Acids Res (2010) 0.94
Cartilage hair hypoplasia mutations that lead to RMRP promoter inefficiency or RNA transcript instability. Am J Med Genet A (2007) 0.94
Recombinant human monoclonal autoantibodies specific for citrulline-containing peptides from phage display libraries derived from patients with rheumatoid arthritis. J Rheumatol (2003) 0.94
Identity of the RNase MRP- and RNase P-associated Th/To autoantigen. Arthritis Rheum (2002) 0.93
Autoantibodies to citrullinated (poly)peptides: a key diagnostic and prognostic marker for rheumatoid arthritis. Autoimmunity (2004) 0.91
RNase MRP and disease. Wiley Interdiscip Rev RNA (2010) 0.91
Peptidylarginine deiminase expression and activity in PAD2 knock-out and PAD4-low mice. Biochimie (2012) 0.90
An important step towards completing the rheumatoid arthritis cycle. Arthritis Res Ther (2008) 0.89
Cartilage-hair hypoplasia-associated mutations in the RNase MRP P3 domain affect RNA folding and ribonucleoprotein assembly. Biochim Biophys Acta (2007) 0.89
Viperin mRNA is a novel target for the human RNase MRP/RNase P endoribonuclease. Cell Mol Life Sci (2010) 0.88
Experimental autoimmune encephalomyelitis induction in peptidylarginine deiminase 2 knockout mice. J Comp Neurol (2006) 0.88
αB-crystallin stimulates VEGF secretion and tumor cell migration and correlates with enhanced distant metastasis in head and neck squamous cell carcinoma. BMC Cancer (2013) 0.87
Anti-citrullinated fibronectin antibodies in rheumatoid arthritis are associated with human leukocyte antigen-DRB1 shared epitope alleles. Arthritis Res Ther (2012) 0.87
Doughnuts dealing with RNA. Nat Struct Mol Biol (2005) 0.87
The human exosome and disease. Adv Exp Med Biol (2011) 0.86
Heat shock factor 1 is inactivated by amino acid deprivation. Cell Stress Chaperones (2012) 0.85
Apoptotic modifications affect the autoreactivity of the U1 snRNP autoantigen. Autoimmun Rev (2005) 0.84